These data indicate that the AKT/MAPK signaling pathway accounts for at least part of the HOXB7-mediated increase in invasiveness and proliferation, and that targeting this axis can inhibit these features in GC cell lines. This evidence concerns the gene AKT1 and gastric cancer.